Transcriptomic Immune-related Signature Predictive of Chemoradiotherapy Response in Anal Squamous Cell Carcinoma
This study identifies a transcriptomic immune-related signature, characterized by CD8+ central memory T cell enrichment and tertiary lymphoid structures, that effectively predicts chemoradiotherapy response and survival outcomes in anal squamous cell carcinoma patients, while also revealing that high tumor mutational burden correlates with poorer prognosis despite its lack of association with treatment response.